Releases - Biotage

View:

2010

 

Found press releases

 

Biotage AB (publ) – disclosure notice of substantial holding of shares

11/4/2010 7:00 AM EST
Biotage AB (publ) has as of 4 November 2010 bought back an aggregate of 8,848,632 shares under the re-purchase program resolved at the Annual General Meeting with the shareholders on 29 April 2010. The Company`s aggregated holding of own shares corresponds to 10 percent of the total amount of shares and votes in the Company.

The total amount of shares outstanding, including shares held in treasury, amounts to...

Biotage AB Nomination Committee

10/27/2010 10:24 AM EST
A Nomination Committee consisting of shareholder representatives and the Chairman of the Board of Directors has been formed for Biotage AB. The Nomination Committee shall, before the Annual General Meeting 2011, prepare proposals for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual General Meeting, the determination of fees and matters pertaining...

Biotage AB (publ) – board member Staffan Lindstrand leaves his assignment

10/27/2010 4:30 AM EST
Staffan Lindstrand, partner of HealthCap, has today given notice that he leaves his assignment as member of Biotage’s Board of Directors.

HealthCap sold its entire shareholding in Biotage at the end of August 2010. 

 

Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for...

Interim report January - September 2010

10/26/2010 6:22 AM EST
Third quarter 2010                                                                                                 

· Net sales increased by 21 % to 109.5 MSEK (90.6). At comparable exchange rates sales increased by 24 %.
· The operating result amounted to 4.8 MSEK (2.0).
· The result after tax amounted to 4.7 MSEK (1.2).
· Earnings per share amounted to 0.06 SEK (0.01).
· The cash flow from operating...

Interim report January - June 2010

8/13/2010 2:30 AM EST


· Group net sales in the second quarter amounted to 103.5 MSEK (104.4). In the period January – June, 2010 Group net sales amounted to 203.4 MSEK (204.0). At comparable exchange rates net sales increased by 5 percent in the second quarter and by 9 percent the first six months. Adjusted for the acquisitions of MIP and Caliper, net sales decreased by 4 percent in the quarter and increased by 5 percent in the...

Biotage AB (publ) – disclosure notice of substantial holding of shares

7/1/2010 2:30 AM EST
Biotage AB (publ) has on 30 June 2010 bought back 56,000 shares. The Company`s aggregated holding of own shares thereby amounts to 4,441,987 shares, corresponding to 5.02 percent of the total amount of shares and votes in the Company. 

The total amount of shares outstanding, including shares held in treasury, amounts to 88,486,320.

 

Contact:                                  
Torben Jörgensen, President...

Biotage appoints Anders Wikström as Vice President of Operations and Anthony Ree...

5/31/2010 3:21 AM EST
Anders Wikström has been responsible for Biotage’s Research and Development since 2007. Anthony Rees has been CEO of MIP Technolgies, which was recently acquired by Biotage.
”I am really glad to welcome Anthony Rees to Biotage. Anthony has vast experiences of development of both research instruments and consumables within Sample Prep, an important focus area of Biotage. We will have great benefit of Anthony’s...

Biotage AB launches share buy-back

5/24/2010 2:30 AM EST
The board of directors of Biotage AB (publ) has resolved to start a share buy-back program in accordance with the Annual General Meeting’s resolution to authorize the board to decide on the acquisition and sale of the company’s own shares.
At the Annual General Meeting held on 29 April 2010, the board was authorized to decide on the acquisition and sale of the company’s own shares up and until the forthcoming...

Biotage AB Acquires SPE Extraction and Evaporation Products from Caliper Life Sc...

5/18/2010 2:30 AM EST
Biotage AB (STO: BIOT), a global leader in tools and technology for medicinal and analytical chemistry, and Caliper Life Sciences, Inc. (NASDAQ: CALP) today announces a transaction under which Biotage is acquiring extraction and evaporation product lines for Sample Preparation from Caliper.

Biotage is acquiring the RapidTrace® and TurboVap® product lines and all associated assets for a sum of USD 16,5m. These...

Resolutions at the Annual General Meeting in Biotage AB on April 29, 2010

4/30/2010 3:00 AM EST
At the Annual General Meeting held in Biotage AB (Reg. No. 556539-3138) on April 29, 2010, the following resolutions were passed, among others.

Appropriation of the company’s result

The General Meeting resolved a dividend of SEK 0.20 per share, which in aggregate is a dividend in the amount of no higher than SEK 17,697,264.
Record date for dividend was resolved to be Tuesday, 4 May 2010.

Board of Directors

The...

Biotage

Biotage accelerates the drug discovery and development process and increases the knowledge of the importance of the genetic make-up by providing complete solutions for medicinal chemistry research and applied genetic ana...

View more


  CONTACT